A new interventional radiology procedure to treat #bloodclots no longer requires thrombolytic agents. Learn more: http://ow.ly/U4yM30o2QAT @ericjvelazquez @YaleIMed @YaleMedicine @YaleMed @ZibaKashef – New Treatment to Remove Clots offers Dramatic Results by Jane E. Dee March 14, 2019 #time #DifferentTechnologies #internet #country #coun tries #intentions #reading #typing #DifferentInfluences #health #longevity #feelings #life #people #person #actions #mind #Importance

https://medicine.yale.edu/intmed/cardio/news_calendar/article.aspx?id=19625

Do the downloads!! Share!! The diffusion of very important information and knowledge is essential for the world progress always!! Thanks!!

  • – > Mestrado – Dissertation – Tabelas, Figuras e Gráficos – Tables, Figures and Graphics – ´´My´´ Dissertation @ #Innovation #energy #life #health #Countries #Time #Researches #Reference #Graphics #Ages #Age #Mice #People #Person #Mouse #Genetics #PersonalizedMedicine #Diagnosis #Prognosis #Treatment #Disease #UnknownDiseases #Future #VeryEfficientDrugs #VeryEfficientVaccines #VeryEfficientTherapeuticalSubstances #Tests #Laboratories #Investments #Details #HumanLongevity #DNA #Cell #Memory #Physiology #Nanomedicine #Nanotechnology #Biochemistry #NewMedicalDevices #GeneticEngineering #Internet #History #Science #World

Pathol Res Pract. 2012 Jul 15;208(7):377-81. doi: 10.1016/j.prp.2012.04.006. Epub 2012 Jun 8.

The influence of physical activity in the progression of experimental lung cancer in mice

Renato Batista Paceli 1Rodrigo Nunes CalCarlos Henrique Ferreira dos SantosJosé Antonio CordeiroCassiano Merussi NeivaKazuo Kawano NagaminePatrícia Maluf Cury


Impact_Fator-wise_Top100Science_Journals

GRUPO_AF1 – GROUP AFA1 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO AFAN 1 – GROUP AFAN1 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO_AF2 – GROUP AFA2 – Aerobic Physical Activity – Atividade Física Aeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

GRUPO AFAN 2 – GROUP AFAN 2 – Anaerobic Physical Activity – Atividade Física Anaeróbia – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

Slides – mestrado – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

CARCINÓGENO DMBA EM MODELOS EXPERIMENTAIS

DMBA CARCINOGEN IN EXPERIMENTAL MODELS

Avaliação da influência da atividade física aeróbia e anaeróbia na progressão do câncer de pulmão experimental – Summary – Resumo – ´´My´´ Dissertation – Faculty of Medicine of Sao Jose do Rio Preto

https://pubmed.ncbi.nlm.nih.gov/22683274/

Abstract

Lung cancer is one of the most incident neoplasms in the world, representing the main cause of mortality for cancer. Many epidemiologic studies have suggested that physical activity may reduce the risk of lung cancer, other works evaluate the effectiveness of the use of the physical activity in the suppression, remission and reduction of the recurrence of tumors. The aim of this study was to evaluate the effects of aerobic and anaerobic physical activity in the development and the progression of lung cancer. Lung tumors were induced with a dose of 3mg of urethane/kg, in 67 male Balb – C type mice, divided in three groups: group 1_24 mice treated with urethane and without physical activity; group 2_25 mice with urethane and subjected to aerobic swimming free exercise; group 3_18 mice with urethane, subjected to anaerobic swimming exercise with gradual loading 5-20% of body weight. All the animals were sacrificed after 20 weeks, and lung lesions were analyzed. The median number of lesions (nodules and hyperplasia) was 3.0 for group 1, 2.0 for group 2 and 1.5-3 (p=0.052). When comparing only the presence or absence of lesion, there was a decrease in the number of lesions in group 3 as compared with group 1 (p=0.03) but not in relation to group 2. There were no metastases or other changes in other organs. The anaerobic physical activity, but not aerobic, diminishes the incidence of experimental lung tumors.

Information For Yale School of MedicineInternal Medicine

Cardiovascular Medicine

share tweet email

New Treatment to Remove Clots offers Dramatic Results

by Jane E. Dee March 14, 2019

Jeffrey Pollak, MD, has seen many incremental changes in medicine over the years, but rarely any game changers.

The Robert I. White, Jr. Professor of Radiology & Biomedical Imaging at Yale School of Medicine, (YSM) Pollak had a game-changing moment earlier this year while performing a minimally invasive procedure on a patient with life-threatening blood clots in his lungs.

There are few things in medicine that are game changers. This is a quantum change in terms of what we can now do to treat our patients.” Jeffrey Pollak, MD

Through a tiny incision in the skin, Pollak guided a catheter into the pulmonary artery to the clots. As he retracted the catheter, he used a suction device to first pull the clots out of the artery and then out of the patient entirely through the skin incision.

“You could see the patient, who had been barely able to breathe, revive on the table as the clots were removed,” said Hamid Mojibian, MD, associate professor of Radiology & Biomedical Imaging at YSM who performed the interventional radiology (IR) procedure with Pollak.

“Such an immediate thrombectomy allowed the patient to turn the corner, right on the table, even before getting out to recovery,” said Kevin Kim, MD, professor of Radiology & Biomedical Imaging at YSM and the IR chief.

A main benefit of the IR procedure is that it does not require the use of thrombolytic agents –clot-busting medicines that can result in bleeding elsewhere in the body, said Pollak. “This expands our ability to treat older patients, or patients with other medical issues who are at a higher risk for bleeding,” he said.

Photo credit: Inari Medical

Interventional radiologists at YSM are the first in Connecticut and among the first in the Northeast to successfully perform a pulmonary thrombectomy with the new mechanical device that does not require the use of the clot-dissolving drugs or a surgical incision into a blood vessel.

“With this new, innovative and successful treatment, we can treat our critical patients with a pulmonary embolism more safely and effectively, and save more lives,” Kim said.

Previously, a patient with a pulmonary embolism would spend six to 12 hours receiving thrombolytics with typically a one- to two-day intensive care unit stay. “If an embolism was life-threatening, the patient may require surgery to remove the clot,” Mojibian said.

“We can offer this treatment to our patients because of the collaborative work between radiologists, pulmonologists, hematologists, and the Yale New Haven Health team,” Mojibian said.

“We also have decades of experience in IR,” Pollak added. “So when a new procedure like this comes out, we are primed and ready to do it. We have the expertise to pick it up very quickly.

While other mechanical devices have been used to remove blood clots, they were not as effective and required the use of thrombolytics, although doctors used as little medicine as possible in those cases, Pollak said.

“When I saw the effect of this new procedure, my phrase was it is a game changer. There are few things in medicine that are game changers. Many things provide incremental changes, but these are quantum changes in terms of what we can now do to treat our patients,” Pollak added. A pulmonary embolism occurs when a clot breaks free from a vein and travels to the lung arteries. This can be a medical emergency, requiring quick intervention and treatment. Its symptoms – coughing, chest pain and shortness of breath – resemble many other medical conditions, including heart attack and pneumonia, so it can be difficult to diagnose. It is more likely to arise in people with certain medical conditions such as cancer or those with poor circulation. It is also associated with a sedentary lifestyle and long periods of inactivity, such as sitting during a long airplane ride. The people most at risk, however, are those with other medical issues, such as heart disease and cancer.

This article was submitted by Angel Machon on March 14, 2019.

Related People

Jeffrey Pollak Headshot
Jeffrey Pollak

Robert I. White, Jr. Professor of Radiology and Biomedical Imaging

Hamid Mojibian Headshot
Hamid Mojibian

Associate Professor of Radiology and Biomedical Imaging

Kevin Kim Headshot
Kevin Kim

Professor of Radiology and Biomedical Imaging

Yale School of Medicine Shield

Education Patient Care Research Internal Medicine 330 Cedar St, Boardman 110 P.O. Box 208056 New Haven CT 06520-8056 Contact UsMaps & directionsFind a PhysicianCalendarYale PhonebookIntranetSite EditorTerms & Privacy PoliciesAccessibility at YSMYale University

Yale School of Medicine

© 2019 Yale School of Medicine. Updated 2/11/2019

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s